Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetics of malignant melanoma
Bruce Moran, Romina Silva, Antoinette S. Perry, et al.
Seminars in Cancer Biology (2017) Vol. 51, pp. 80-88
Closed Access | Times Cited: 107

Showing 1-25 of 107 citing articles:

Signal pathways of melanoma and targeted therapy
Weinan Guo, Huina Wang, Chunying Li
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 225
Targeting the ERK Signaling Pathway in Melanoma
Paola Savoia, Paolo Fava, Filippo Casoni, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 6, pp. 1483-1483
Open Access | Times Cited: 151
The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe
Florentia Dimitriou, Regina Krattinger, Egle Ramelyte, et al.
Current Oncology Reports (2018) Vol. 20, Iss. 11
Closed Access | Times Cited: 154
BRAF Gene and Melanoma: Back to the Future
Margaret Ottaviano, Emilio Francesco Giunta, Marianna Tortora, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3474-3474
Open Access | Times Cited: 68
A real‐world pharmacovigilance study of FDA adverse event reporting system events for sildenafil
Yan Wang, Bin Zhao, Haiyan Yang, et al.
Andrology (2023) Vol. 12, Iss. 4, pp. 785-792
Open Access | Times Cited: 24
EZH2 Cooperates with DNA Methylation to Downregulate Key Tumor Suppressors and IFN Gene Signatures in Melanoma
Jessamy Tiffen, Stuart J. Gallagher, Fabian V. Filipp, et al.
Journal of Investigative Dermatology (2020) Vol. 140, Iss. 12, pp. 2442-2454.e5
Open Access | Times Cited: 52
UVA Radiation, DNA Damage, and Melanoma
Seung‐Gi Jin, F.J. Robaina Padrón, Gerd P. Pfeifer
ACS Omega (2022) Vol. 7, Iss. 37, pp. 32936-32948
Open Access | Times Cited: 34
Pioneer Role of Extracellular Vesicles as Modulators of Cancer Initiation in Progression, Drug Therapy, and Vaccine Prospects
Sadaf Jahan, Shouvik Mukherjee, Shaheen Ali, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 490-490
Open Access | Times Cited: 33
Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile
Sukhwinder Singh, Alok Sharma, Vikramdeep Monga, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 27, pp. 8868-8899
Closed Access | Times Cited: 30
Histone Deacetylase (HDAC) Inhibitors: A Promising Weapon to Tackle Therapy Resistance in Melanoma
Kostas Palamaris, Myrto Moutafi, Hariklia Gakiopoulou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3660-3660
Open Access | Times Cited: 30
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
Francesco Mannavola, Stella D’Oronzo, Mauro Cives, et al.
International Journal of Molecular Sciences (2019) Vol. 21, Iss. 1, pp. 52-52
Open Access | Times Cited: 50
CRISPR/Cas mediated epigenome editing for cancer therapy
Imran Ansari, Animesh Chaturvedi, Deepak Chitkara, et al.
Seminars in Cancer Biology (2021) Vol. 83, pp. 570-583
Closed Access | Times Cited: 34
Structural characteristics of native and chemically sulfated polysaccharides from seaweed and their antimelanoma effects
Ester Mazepa, Stellee Marcela Petris Biscaia, Daniel de Lima Bellan, et al.
Carbohydrate Polymers (2022) Vol. 289, pp. 119436-119436
Closed Access | Times Cited: 27
Nanodelivery systems for cutaneous melanoma treatment
Irina Pereira, Carina Monteiro, Miguel Pereira‐Silva, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 184, pp. 214-247
Open Access | Times Cited: 16
Epigenetic modification of gene expression in cancer cells by terahertz demethylation
Hwayeong Cheon, Junho K. Hur, Woochang Hwang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
Ugo Testa, Germana Castelli, Elvira Pelosi
Medical Sciences (2017) Vol. 5, Iss. 4, pp. 28-28
Open Access | Times Cited: 40
Biological Factors behind Melanoma Response to Immune Checkpoint Inhibitors
Magdalena Olbryt, Marcin Rajczykowski, Wiesława Widłak
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 11, pp. 4071-4071
Open Access | Times Cited: 34
Hypomethylating Agents and Immunotherapy: Therapeutic Synergism in Acute Myeloid Leukemia and Myelodysplastic Syndromes
Kah Keng Wong, Rosline Hassan, Nik Soriani Yaacob
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 32
Novel insights into histone lysine methyltransferases in cancer therapy: From epigenetic regulation to selective drugs
Qi-Li Liao, Jie Yang, Shengfang Ge, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 13, Iss. 2, pp. 127-141
Open Access | Times Cited: 21
Morin Hydrate Encapsulation and Release from Mesoporous Silica Nanoparticles for Melanoma Therapy
Catarina Cunha, Diogo Marinheiro, B.J.M. Leite Ferreira, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4776-4776
Open Access | Times Cited: 11
Intelligent hydrogels for treating malignant melanoma
Guopu Chen, Xiyu Wang, Jiaye Li, et al.
Engineered Regeneration (2024) Vol. 5, Iss. 3, pp. 295-305
Open Access | Times Cited: 4
Inflammasome activation in melanoma progression: the latest update concerning pathological role and therapeutic value
Nakaraj Pluetrattanabha, Thanyaporn Direksunthorn, Irfan Ahmad, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
DNA Methylation Array Analysis Identifies Biological Subgroups of Cutaneous Melanoma and Reveals Extensive Differences with Benign Melanocytic Nevi
Simon Schwendinger, Wolfram Jaschke, Theresa Walder, et al.
Diagnostics (2025) Vol. 15, Iss. 5, pp. 531-531
Open Access
Cutaneous melanoma
Alpaslan Tasdogan, Ryan J. Sullivan, Alexander Katalinic, et al.
Nature Reviews Disease Primers (2025) Vol. 11, Iss. 1
Closed Access
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications
Irene Vanni, Enrica T. Tanda, Bruna Dalmasso, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top